Acute Myelomonocytic Leukemia - 190 Studies Found
Completed |
: Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
: |
Active, not recruiting |
: Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers :
|
Completed |
: Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia :
|
Completed |
: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases :
|
Completed |
: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia :
|
Terminated |
: AML Therapy With Irradiated Allogeneic Cells :
|
Recruiting |
: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Recruiting |
: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy :
|
Active, not recruiting |
: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Terminated |
: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|